Last reviewed · How we verify
NCT06400355
Effect of Mannitol on Recovery Pattern After Orthognathic Surgery
NA trial testing Mannitol in Orthognathic Surgery in 60 participants. Participants enrolled and being followed up; not accepting new ones.
1 June 2024
Quick facts
| Lead sponsor | National Cancer Institute, Egypt |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 March 2024 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Mannitol (Mannitol) — full drug profile →
- Ringer's Lactate
Conditions studied
- Orthognathic Surgery — all drugs for Orthognathic Surgery →
Sponsor
National Cancer Institute, Egypt
Who can join
Adults 18 to 65, any sex, with Orthognathic Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to test, whether mannitol infusion in different doses will affect recovery pattern? the investigators hypothesized that infusion of mannitol in doses of 0.5 gm/kg before recovery from anesthesia after orthognathic surgery shortens patients' recovery time, and improves recovery quality, as well as postoperative cognitive function better.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06400355
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mannitol
Trials testing the same drug.
- NCT07433023 — tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy · Phase 2 · not yet recruiting
- NCT06914310 — Memantine as an Additive Therapy in Patients With Traumatic Brain Injury · Phase 2, PHASE3 · not yet recruiting
- NCT06473779 — Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remiss · Phase 3 · active not recruiting
- NCT06540352 — A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term · Phase 2 · active not recruiting
- NCT06841406 — Budesonide as a Treatment for Functional Dyspepsia · Phase 4 · recruiting
Other recruiting trials for Orthognathic Surgery
Currently open trials in the same condition.
- NCT06822127 — Simulation of Facial Soft Tissue in Orthognathic Surgery · NA · recruiting
- NCT07418684 — Accuracy of Maxillary Two Customized 3D Titanium Miniplates Versus Four Customized 3D Miniplates · NA · recruiting
- NCT07006610 — Hilotherapy vs. Kinesio Taping in Orthognathic Surgery Recovery · NA · recruiting
- NCT05708521 — Personalization of Opioid Prescription Following Orthognathic Surgery · Phase 4 · active not recruiting
- NCT06714747 — Soft Tissue Prediction in Orthognathic Surgery by Making Anatomically Accurate Virtual Model · recruiting
Other National Cancer Institute, Egypt trials
Trials by the same sponsor.
- NCT07424638 — Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain · NA · recruiting
- NCT07367568 — Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy · NA · recruiting
- NCT07367581 — Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer · NA · recruiting
- NCT07337330 — Ultrasound Guided External Oblique Intercostal Plane Block Versus Erector Spinae Block for Post Hepatectomy Pain · NA · not yet recruiting
- NCT07390448 — Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy Surgeries · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06400355 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Institute, Egypt
- Last refreshed: 23 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06400355.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing